Connect with us


CBD Treatment Case: Multiple Sclerosis



For those suffering from multiple sclerosis, any lifeline of hope might be an enormous boost. The disease affects millions of people around the world, and can be devastating, with an array of symptoms that impact vision, movement, and control over one’s own body.

By acting against the disease’s perforation tendency in the blood-brain barrier, and by stimulating repair in immune cells, it turns out that CBD can possibly offer a tremendous amount of hope as a therapeutic tool for those suffering from this terrible disease.

But to find out how, we need to understand more about multiple sclerosis.

What is Multiple Sclerosis

As we mentioned above, multiple sclerosis affects the autoimmune system. Most specifically, it destroys a part of the body known as the myelin sheath, which is a layer of insulating tissue that preserves and protects neurons, allowing them to maintain their strength of signal.

MS, as it is often called, currently affects about three million people around the world, with nearly 900 new cases detected in the United States every month.

The symptomology includes a progressive deterioration of myelin, as well as destruction of the nerve signaling responsible for healthy vision, feeling, and movement, as well as cognition. But the most common symptom faced by those suffering from MS is spasticity. Spasticity can be best understood as a contraction or loss of muscular tone that results from unpredictable signals coming from the neurons.

MS has two real types of symptoms: acute flareups and long-term deterioration.

The exact cause of the condition is actually not fully understood. But scientists believe at this point that there are three primary pathways by which it progresses: inflammation of brain tissue, loss of nerve conductivity, and neuron demyelination.

Diagnosis of the disease is generally done through medical imaging using MRI scans. Glial scars – also known as scleroses – appear throughout the body, and are generally accepted as the diagnostically conclusive symptom.


It may not shock you to hear that there is no cure at this point for MS. There are several medications that are often prescribed, but their purpose is simply to limit the severity of the short term flareups – the acute symptoms. These are generally administered upon detection of a flareup underway.

However, such drugs tend to have many adverse side effects even including an increased risk of development of cancer and a decrease in the efficacy of the immune system in the presence of pathogens.

Enter CBD

The fact that many people suffering from MS have found cannabis to be a useful tool for treatment and therapy has suggested researchers toward the research of other cannabinoids and how they may be impacting those experiences. This also points scientists to a potential new understanding of the path of development of the disease.

As we have covered, the endocannabinoid system is an important regulatory system within the mammalian physiology. This system is important in regulating hundreds of different functions and processes within the body. Interestingly, and poignant to this discussion, the endocannabinoid system appears to play a large role in the regulation and maintenance of the immune system.

When this system becomes dysfunctional or deficient, many problems can result.

Now, it’s very important to understand that glial cells are essentially the immune system of the brain. In multiple sclerosis, researchers have found that this overlap of impact zone may lead to a potential for CBD to function in helping those suffering from the disease cope with their symptoms.

There are plenty of anecdotal pieces of evidence supporting this postulation. It only remains now for us to establish more concrete and rigorous research such that we may get the medical establishment to seize on to this potential game changing tool.

Continue Reading


CannTrust Holdings Inc (NYSE:CTST) Penetrates Into The United States After Investing $20 Million



CannTrust Holdings Inc (NYSE:CTST), a Canadian company that produces and sells medical and recreational marijuana has announced the expansion of its business into the United States.

The Canadian firm revealed that it signed a Letter of Intent through which it will start working with Elk Grove Farming Company, LLC to access more than 3,000 hemp production acres in California. The two companies struck a joint partnership that will allow CannTrust to secure a footing in the California market which is one of the biggest cannabis markets in the U.S.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity,” stated CannTrust CEO Peter Aceto.

CannTrust is financially ready to tap into the U.S market

The CannTrust CEO also noted that the company will take advantage of its experience in the formulation of standardized CBD products as part of its strategy to enter the U.S market. Mr. Aceto also revealed that his company’s successful equity offering provided enough financial muscle to fuel its ambitious expansion plans.

CannTrust aims to be among the leading and trusted suppliers of high-quality, standardized CBD formulations derived from hemp. The company believes that there will be an increasing demand for high-grade CBD formulations from international retailers. It therefore makes sense to invest in processes that will add value to the end product such as genetic studies and expert growing practices to achieve the highest safety and quality standards.

Elk Grove and CannTrust will each have 50% ownership in their joint operations. Elk Grove is an ideal partner for the endeavor because it has years of farming experience in a variety of products. Its focus includes products designed for crop protection, supply, and input. Its operations are distributed across California, which means that the groundwork has already been laid for the partnership. It will thus be easier for the CannTrust to penetrate into the California market.

Elk Grove executive Morgan Houchin stated that his company was excited about the partnership with CannTrust. He added that his firm’s experience in farming operations will be a great combination with CannTrust’s experience in creating class-leading formulations.

Continue Reading


Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Strikes Broker Deal With Carlin Group



Lifestyle brand management firm Rocky Mountain High Brands Inc (OTCMKTS:RMHB) announced on Wednesday that it secured a broker deal with Carlin Group for its products in the retail space.

The broker agreement will allow Carlin to represent RMHB’s CBD-infused drinks through the HEMPd brand. It will also represent beverages infused with Hempseed extract under RMHB brands. The deal will also cover CBD-infused wellness products such as lotions, water-soluble solutions, capsules, gummies and tinctures as part of the HEMPd brand. Spirit Water will also be covered under the agreement.

The RMHB-Carlin broker deal covers multiple states. They include Missouri, Nebraska, Texas, South Dakota, North Dakota, Minnesota, Wisconsin, Illinois, Pennsylvania, Tennessee, Kentucky, Ohio, Indiana, and Michigan.

“We are very excited about the opportunity to have our entire product line represented by Carlin Group,” stated RMHB CEO Michael Welch.

The Carlin broker deal will boost RMHB’s exposure

Welch noted that the broker deal will strategically allow RMHB to leverage optimal exposure to mass marketers, grocery store chains, convenient stores, major retailers and other types of outlets. The company would not have managed to reach such a wide range of outlets cost-effectively without a broker deal.

The RMHB CEO also added that his company and Carlin will maintain a close collaboration so that they can facilitate retail availability of RMHB products. Welch also revealed that RMHB reviewed numerous other retail introduction options. This was before settling on Carlin which the company believes is the best-suited brand to rapidly get its products onto retail shelves.

Carlin Group’s Managing Director Albert Vergilio noted in a statement that his company was excited to host RMHB and the CBD-based products that are part of its HEMPd brand in Carlin’s new CBD division. He also added that it is part of investing in the future of CBD considering the fast-tracked popularity of CBD products, and the regulations that govern them.

Carlin’s sales team will undergo some training to get them acquainted with RMBH’s products. The sales team will then hold meetings with corporate customers as part of the retail rollout of the products. Sales that will be part of the broker deal are expected to kick off in Q3.

Continue Reading


Wildflower Brands Inc (OTCMKTS:WLDFF) Establishes Footprint Across The US With PO For Hemp CBD Products From Dillard’s Department Stores And Eyes Markets In Texas And Florida



Wildflower Brands Inc (OTCMKTS:WLDFF) has announced establishing a nationwide presence with a PO from Dillard’s Department store. The company has fulfilled the PO received from Dillard.

Hemp CBD products in 292 locations

Dillard’s department store will showcase the premium hemp CBD products of Wildflower in its 292 locations across the US. With its best practices and transparency, Wildflower is eyeing the key markets in Texas and Florida. The company will educate the customers in these regions about salable products. Wildflower has received subsequent orders from Dillard’s and is fulfilling the requirements.

Chief Executive Officer of Wildflower, William Maclean said the supply of CBD infused products to Dillard’s Department stores doubles the existing retail locations in the nation. The company aims to capitalize on its brand to become a household name. It will improve loyalty building because of the reputation and respect of Dillard’s as a retailer. Wildflower aims to provide health and wellness benefits of its CBD infused products to the customers in the US through Dillard’s.

Signs a deal with Highmark Interactive

Wildflower has signed a deal to use EQ – Brain Tracking, mobile software of Highmark Interactive, in the clinical research to study the functional neurological and cognitive effects of CBD. The company aims to get meaningful results and data that help to understand the functional and cognitive neurological properties of the cannabinoids.

William said the company would collect testimonials from the customers on its products that provide the health and wellness needs using plant-based solutions. The company will strive to improve the products, and the research helps it to reach that goal and growth with continued investments.

Acquires City Cannabis Corp

Wildflower has signed an LOI on April 3, 2019, to take over City Cannabis Corp. The company will issue its 60 million common shares for the takeover. The companies will complete the acquisition on receiving advice from corporate, tax, and securities law departments.

The cannabis retailer City Cannabis holds two licenses in the City of Vancouver to market cannabis. It is generating profits through operating dispensaries in Vancouver. The acquisition helps Wildflower to expand retail footprint using the expertise of City Cannabis.

Continue Reading

Trending Stories